New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2013
08:32 EDTROSGRosetta Genomics receives two U.S. patent allowances
Rosetta Genomics announced that the company has received  two notices of allowance from the U.S. Patent and Trademark Office for Patent Applications 12/661,041 and 12/850,091. The allowed claims of 12/661,041, entitled "microRNAs and Uses Thereof," cover the composition of matter for miR-29c, as well as sequence variants, a vector and a probe comprising the same.  miR-29c is a core element in the company's lead commercial product, miRview mets2 diagnostic assay for the identification of the tumor of origin in Cancer of Unknown and Uncertain Primary. The allowed claims of 12/850,091, entitled "Viral and Viral Associated MiRNAs and Uses Thereof," cover the composition of matter for herpes simplex virus 1 miR-H3, miR-H4 and miR-H5, as well as sequence variants, a vector and a complementary sequence comprising the same.
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 26, 2015
08:31 EDTROSGRosetta Genomics receives U.S. patent allowance for kidney cancer test
Subscribe for More Information
March 25, 2015
08:02 EDTROSGRosetta Genomics to launch Admera's OncoGxOne
Subscribe for More Information
March 17, 2015
08:24 EDTROSGRosetta Genomics to host conference call
Conference call to provide corporate and financial updates will be held on March 17 at 10 am. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use